Professor Xu Yanling Fibrosis Clinical Experience In Probe Between The Treatment Of Pulmonary Medicine

Pulmonary fibrosis is the outcome of a variety of lung diseases, the cough,expectoration, progressive shortness of breath on exertion as the main clinicalmanifestations. Its pathogenesis is not very clear, long course of disease, oftenshow progressive. Modern medicine for the treatment effect is poor, the prognosisis poor At present, there is no the corresponding records of traditional Chinesemedicine。Instructors believe that the disease is "lung disease" category, thetotal by lung kidney two empty, because the external, internal injuries, andendogenous phlegm and blood stasis, phlegm and blood stasis, damage of Qi andYin, stagnation in the lung, the lung dryness Jin injury, Pulmonary losingnutrition, lobar atrophy of waste and the incidence of the disease. In thetreatment of this disease should be reinforcing and reducing the standard cardof this disease be treated at the same time. In this paper, from the name ofdisease, etiology and pathogenesis, the clinical treatment and medical recordsfor four aspects to introduce the clinical experience of interstitial lungdisease by application of traditional Chinese medicine treatment of ProfessorXu Yanling.